The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Genentech
Stock and Other Ownership Interests - Roche
Honoraria - Genentech, Inc. employee
Travel, Accommodations, Expenses - Genentech, Inc. employee
 
Employment - Genentech
Stock and Other Ownership Interests - Genentech
Fixed duration subcutaneous (SC) mosunetuzumab (Mosun) in patients with previously untreated high-tumor burden follicular lymphoma (FL): Interim results from the phase II MorningSun study.
 
Ian Flinn
Consulting or Advisory Role - Abbvie; BeiGene; Genentech; Genmab; Kite/Gilead; Vincerx Pharma
Research Funding - 2seventy bio (Inst); Abbvie (Inst); AstraZeneca (Inst); BeiGene (Inst); Bristol Myers Squibb (Inst); Celgene (Inst); City of Hope (Inst); Epizyme (Inst); Fate Therapeutics; Genentech (Inst); Gilead Sciences (Inst); IGM Biosciences (Inst); Incyte (Inst); Innocare (Inst); Janssen (Inst); Kite, a Gilead company (Inst); Loxo (Inst); Marker Therapeutics (Inst); Merck (Inst); MorphoSys (Inst); Myeloid Therapeutics (Inst); Myeloid Therapeutics (Inst); Novartis (Inst); Novartis (Inst); Novartis (Inst); Nurix (Inst); Pfizer (Inst); Roche (Inst); Seagen (Inst); TG Therapeutics (Inst); Vincerx Pharma (Inst)
 
John Burke
Consulting or Advisory Role - Abbvie; AstraZeneca; BeiGene; Bristol Myers Squibb; CRISPR Therapeutics; Genentech/Roche; Genmab; Lilly; Novartis; Regeneron; Seagen
Travel, Accommodations, Expenses - Genentech/Roche
 
Jeff Sharman
Employment - US Oncology Network
Honoraria - Research to Practice
Consulting or Advisory Role - Abbvie; AstraZeneca; BeiGene; Bristol-Myers Squibb; Genentech; Janssen Oncology; Lilly; Merck
 
Bertrand Anz
Research Funding - Formerly with Sarah Cannon Research Institute. Currently with the Greco-Hainsworth Centers for Research. (Inst)
 
Richard Zuniga
Consulting or Advisory Role - Bristol-Myers Squibb; Mirati Therapeutics
 
Aung Tun
Honoraria - Curio Science
Consulting or Advisory Role - ADC Therapeutics
 
Prachi Jani
Employment - Genentech
Stock and Other Ownership Interests - Genentech
 
Juliana Biondo
No Relationships to Disclose
 
Mei Wu
No Relationships to Disclose
 
Yong Mun
Employment - Roche/Genentech
Stock and Other Ownership Interests - Roche/Genentech
 
Vivek S. Chopra
Employment - Genentech, Inc. [Roche]
Stock and Other Ownership Interests - Genentech, Inc. [Roche]
Travel, Accommodations, Expenses - Genentech, Inc. [Roche]
 
Rona Farighi
Employment - Genentech
Stock and Other Ownership Interests - Genentech/Roche [employer]
Travel, Accommodations, Expenses - Genentech/Roche [employer]
 
Tony Lin
Employment - Genentech
Leadership - Genentech
Stock and Other Ownership Interests - Genentech
Travel, Accommodations, Expenses - Genentech
 
Jose Villasboas
Consulting or Advisory Role - Curio Science (Inst); Kite/Gilead (Inst); Regeneron (Inst); TG Therapeutics (Inst)
Research Funding - Aptose Biosciences (Inst); Celgene/Bristol-Myers Squibb (Inst); Enterome (Inst); Epizyme (Inst); Genentech/Roche (Inst); Regeneron (Inst)
 
Lihua Budde
Consulting or Advisory Role - Abbvie; AstraZeneca; Bristol-Myers Squibb; Crispr Therapeutics; Genmab; Janssen; Kite, a Gilead Company; Nurix; Roche
Research Funding - AstraZeneca